You are here: Industry Insights > cancer

News List

Researchers determine how a specific protein regulates tumor growth worldpharmanews
January 03, 2020
Immune checkpoints are surface proteins that cancer cells use to evade immune response. These surface proteins are critical for cancer cell growth and drugs targeting these proteins have ...
Lynparza approved by FDA to treat germline BRCA-mutated metastatic pancreatic cancer europeanpharmaceuticalreview
January 03, 2020
The FDA has approved Lynparza as a first-line treatment after it reduced the risk of disease progression or death by 47 percent in patients.
Young Cancer Patients Fare Better on Private Insurance drugs
January 02, 2020
The odds of surviving childhood?cancer?may be influenced by the type of health insurance a young patient has, researchers say.
Breast Density Alerts Might Not Be Helping Women drugs
January 02, 2020
Having dense breast tissue raises a woman's odds for?breast cancer, so many states require providers to notify women if a mammogram finds they have dense breast tissue.
Endoscopic Approaches Feasible in Surgery for Sinonasal Cancer drugs
January 02, 2020
Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online December in?Head & Neck.
Incidence of Early-Onset Gastric Cancer Increasing in the U.S. drugs
January 02, 2020
The incidence of early-onset gastric cancer has been increasing in the United States, and it seems to be distinct clinically and genetically from late-onset gastric cancer ...
Stomach Cancer Appears Different in Younger Patients drugs
January 02, 2020
Stomach cancer among many people under 60 appears more deadly than when it occurs to older people, a new study finds.
Obesity May Boost Effectiveness of a Lung Cancer Therapy drugs
December 31, 2019
Obesity?is seldom a friend to health, but in one medical context it might give patients a slight advantage, new research suggests.
Risk-Based Approach Could Help Target Prostate Cancer Screening drugs
December 30, 2019
Risk-tailored screening could potentially reduce overdiagnosis and improve the cost-effectiveness of a prostate cancer screening program, according to a study published online December in?PLOS Medicine.
Public Insurance Tied to Lower Cancer Survival in Young Patients drugs
December 30, 2019
Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online December in?Cancer Medicine.